Ignite Creation Date:
2024-05-06 @ 10:27 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03262974
Status:
COMPLETED
Last Update Posted:
2023-10-27
First Post:
2017-08-24
Brief Title:
Effect of Pharmacogenetics on Imatinib Plasma Level and Response
Sponsor:
Organization:
Assiut University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
DNA will be extracted from blood samples and frozen at -80 for further analysis
Enrollment Count:
60
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 43357 |
Who Masked List: